Future Cardiol. 2012;8(4):647-670. Although redox-induced damage is likely involved in anthracycline-induced cardiotoxicity, some evidence suggests that it is not the only mechanism at play. Several ...
Black patients with cancer are significantly more likely to experience cardiotoxicity and congestive heart failure related to chemotherapy than White cancer patients are, a research review indicates. ...
Radiation and chemotherapy for Hodgkin's lymphoma can lead to late-onset cardiotoxicity, including coronary artery disease. Self-advocacy and detailed medical history are crucial for timely diagnosis ...
Scholastic Achievements of Childhood Leukemia Patients: A Nationwide, Register-Based Study The design and efficacy of the major adjuvant trastuzumab trials was assessed, including the National ...
Please provide your email address to receive an email when new articles are posted on . A decrease in left ventricular ejection fraction to below normal levels occurred more frequently among women ...
Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human ...
Please provide your email address to receive an email when new articles are posted on . Black race was associated with 71% greater odds of chemotherapy-related cardiotoxicity vs. white or non-Black ...
A new meta-analysis published in OMICS: A Journal of Integrative Biology helps shed light on how changes in mitochondria-related gene expression may cause the cardiotoxicity associated with the cancer ...
CHICAGO -- Sacubitril/valsartan (Entresto) was effective at keeping cardiotoxicity at bay in high-risk people receiving anthracycline chemotherapy in the SARAH trial. Cancer patients were less likely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results